Sign Up
Stories
Adial Pharmaceuticals Raises $3.5M for AD04
Share
Adial Pharmaceuticals Boosts AD04 Develo...
Adial Pharmaceuticals Raises $3.5 Millio...
Adial Pharmaceuticals Raises $3.5M for D...
ADMA Biologics CFO Transition Announceme...
ADMA Biologics CFO Transition Revealed
ADOCIA Files 2023 Registration Document
Overview
API
Adial Pharmaceuticals has announced the exercise of warrants generating $3.5 million in gross proceeds, with a focus on utilizing the funds for general corporate purposes and supporting regulatory activities for AD04, its Alcohol Use Disorder treatment drug.
Ask a question
How might the exercise of warrants by Adial Pharmaceuticals reflect broader trends in the biopharmaceutical industry?
How will the $3.5 million in gross proceeds impact the development and availability of AD04 for Alcohol Use Disorder treatment?
What other initiatives or research areas is Adial Pharmaceuticals focusing on apart from AD04?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage
finan
globe